Dow Up0.36% Nasdaq Up0.12%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
1.48 Down 0.05(3.27%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   4   9  
Cost of Revenue -   -   -   -  
Gross Profit -   -   4   9  
Operating Expenses
Research Development6,721  7,690  7,679  8,995  
Selling General and Administrative2,813  2,470  2,253  2,101  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,534) (10,160) (9,928) (11,087)
Income from Continuing Operations
Total Other Income/Expenses Net(540)12  (29)565  
Earnings Before Interest And Taxes(10,074)(10,148)(9,957)(10,522)
Interest Expense(260)260  279  807  
Income Before Tax(9,814)(10,408)(10,236)(11,329)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(9,814)(10,408)(10,236)(11,329)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (9,814) (10,408) (10,236) (11,329)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (9,814) (10,408) (10,236) (11,329)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.